Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Medicine International
Join Editorial Board Propose a Special Issue
Print ISSN: 2754-3242 Online ISSN: 2754-1304
Journal Cover
September-October 2025 Volume 5 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-October 2025 Volume 5 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells

  • Authors:
    • Daiki Ohsaki
    • Kazuki Kanayama
  • View Affiliations / Copyright

    Affiliations: Graduate School of Health Science, Suzuka University of Medical Science, Suzuka, Mie 510‑0293, Japan
    Copyright: © Ohsaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Article Number: 59
    |
    Published online on: August 4, 2025
       https://doi.org/10.3892/mi.2025.258
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Gastric cancer (GC) is classified into four molecular subtypes according to the Epstein‑Barr virus‑positive status, microsatellite instability, genomic stability and chromosomal instability (CIN). The CIN subtype is characterized by a high frequency of gene amplifications in receptor tyrosine kinases (RTKs) and a poor prognosis. In addition, the CIN subtype often exhibits intratumoral heterogeneity and indicates insensitivity to targeted drugs. Elucidating the molecular mechanisms of CIN in GC is therapeutically crucial; however, the molecular mechanisms involved are not yet fully understood. The kinetochore‑associated 1 (KNTC1) gene encodes kinetochore‑associated protein 1 (KNTC1), a major component of the outer kinetochore. The downregulation of KNTC1 causes a high frequency of lagging chromosomes and consequent aneuploidy and CIN in Drosophila and Caenorhabditis elegans. However, the association between KNTC1 and CIN in GC has not yet been clarified. Therefore, the present study investigated the role of KNTC1 in GC CIN. It was found that GC cell lines with a high frequency of lagging chromosomes had a low KNTC1 mRNA expression. Notably, KNTC1 knockdown increased the frequency of lagging chromosomes in GC cell lines. In particular, GC cell lines with the amplification of RTK genes exhibited a significant increase in the frequency of lagging chromosomes. On the whole, the findings of the present study suggest that the suppression of KNTC1 expression may contribute to CIN in GC and may be involved in the generation of intratumoral genetic heterogeneity in GC.

Introduction

In 2020, ~770,000 patients succumbed due to gastric cancer (GC), rendering GC the fourth most common cause of cancer-related mortality worldwide, surpassed only by lung, colorectal and liver cancers (1). As GC exhibits histological and genetic heterogeneity, the development of biomarker-based molecularly targeted therapeutics has lagged behind that of other cancer types (2). However, The Cancer Genome Atlas research program has succeeded in characterizing GC at the genomic level, yielding a system for classifying GC into four molecular subtypes according to the Epstein-Barr virus-positive status, microsatellite instability, genomic stability and chromosomal instability (CIN), with the aim of simplifying the treatment and diagnosis of GC (2,3).

The CIN subtype accounts for ~50% of GC cases and is characterized by the amplification of receptor tyrosine kinase (RTK) genes, a high frequency of TP53 mutations (in 70% of cases) and CIN, which is indicated by a high frequency of aneuploidy (4,5). In addition, the CIN subtype is known to exhibit intratumoral heterogeneity, which is involved in tumor relapse owing to the acquisition of cellular insensitivity to targeted drugs (6-8). Therefore, elucidating the molecular mechanisms of CIN in GC is of utmost therapeutic importance. However, these mechanisms are not yet fully understood.

The kinetochore-associated 1 (KNTC1) gene encodes kinetochore-associated protein 1 (KNTC1), a protein component of the outer kinetochore that is essential for the association of chromosomes and spindle microtubules. KNTC1 forms a complex with ZW10 and ZWILCH during mitosis. This complex, which is known as the RZZ complex, is involved in the activation of the spindle assembly checkpoint (SAC), the kinetochore-dependent recruitment of the Mad1/Mad3 and dynein/dynactin complex and the formation of the kinetochore corona in the outermost layer of the kinetochore (9-14). In particular, the activation of the SAC delays anaphase when there is a lack of proper connection between kinetochores and spindle microtubules, allowing for homogenous chromosome segregation (15,16). The depletion or loss of function of various kinetochore proteins, including KNTC1, has been reported to cause lagging chromosomes, resulting in abnormal chromosome segregation and subsequent aneuploidy and CIN in Drosophila and Caenorhabditis elegans (16-18). However, the role of the KNTC1 gene in GC is poorly understood.

It was hypothesized that the abnormal function of KNTC1 may be associated with the mechanism of CIN in GC. Therefore, the present study investigated the role of KNTC1 in GC CIN.

Materials and methods

Cell lines and culture conditions

The human GC cell lines, NCI-N87 (exhibiting human epidermal growth factor receptor type 2 gene amplification; cat. no. CRL-5822, American Type Culture Collection), KATOIII [exhibiting fibroblast growth factor receptor type 2 gene amplification; cat. no. JCRB0611, Japan Collection of Research Bioresources (JCRB) Cell Bank] and MKN74 (without amplification of RTK genes; cat. no. JCRB0255, JCRB), and the human normal fibroblast cell line, TIG-1-20 (cat. no. JCRB0501, JCRB), were used in the present study. The cells were cultured in RPMI-1640 medium (cat. no. 30264-56; Nacalai Tesque, Inc.) containing a 10% fetal bovine serum and 0.5% penicillin and streptomycin mixture (cat. no. 09367-34; Nacalai Tesque, Inc.) at 37˚C in an atmosphere containing 5% CO2. The cell cultures were grown in a CO2 incubator (cat. no. MHE-S1301A2-PJ; PHC Holdings Corporation).

Measurement of the frequency of lagging chromosomes

The NCI-N87, KATOIII, MKN74 and TIG-1-20 cells were seeded into 4-well culture slides (cat. no. 192-004; Watson Bio Lab) and cultured for 24 h at 37˚C. After 24 h, the cells were transfected with small interfering RNA (siRNA) targeting KNTC1, as described below. Following transfection, the cells are incubated for an additional 3 days and fixed for 20 min at room temperature with 4% paraformaldehyde (cat. no. 006775-1L; Bioenno Tech, LLC). The slides were washed twice for 5 min each with phosphate-buffered saline (cat. no. 73111; Kanto Chemical Co.) and sealed using coverslips and VECTASHIELD Vibrance Antifade Mounting Medium with DAPI (cat. no. H-1800; Vector Laboratories, Inc.). A total of 50 cells in anaphase, defined according to visible sister chromatid separation, were then observed using a fluorescence microscope (BX53F; Olympus Corporation). Among these 50 cells, the number of lagging chromosomes was counted (Figs. 1 and S1), and the percentage was calculated.

Representative image of lagging
chromosomes in NCI-N87 cells. Chromosomes remained on the metaphase
plate and formed bridges in anaphase (red arrow).

Figure 1

Representative image of lagging chromosomes in NCI-N87 cells. Chromosomes remained on the metaphase plate and formed bridges in anaphase (red arrow).

Reverse transcriptionquantitative polymerase chain reaction (RTqPCR)

Total RNA was extracted from the NCI-N87, KATOIII, MKN74 and TIG-1-20 cells using an RNeasy mini kit (cat. no. 74104; Qiagen, Inc.). cDNA synthesis was performed using reverse transcription with Superscript Ⅳ VILO Master Mix with ezDNase (cat. no. 11766050; Invitrogen; Thermo Fisher Scientific, Inc.). cDNA synthesis reaction was performed at 25˚C for 10 min, 50˚C for 10 min, and 85˚C for 5 min. KNTC1 (Hs00938554_m1) and GAPDH (No. 1902206) primers were obtained from Thermo Fisher Scientific, Inc. (primer sequence information not available). qPCR was performed using TaqMan Fast Advanced Master Mix (cat. no. 4444556; Applied Biosystems; Thermo Fisher Scientific, Inc.) using the following reaction conditions: An initial denaturation at 95˚C for 20 sec, then 40 cycles at 95˚C for 3 sec and 60˚C for 30 sec. mRNA expression was analyzed using the 2-ΔΔCq calculation (19).

Western blot analysis

The NCI-N87, KATOIII, MKN74 and TIG-1-20 cells were lysed in RIPA buffer (cat. no. 08714-04; Nacalai Tesque, Inc.). The cell lysates were then treated using ultrasound and centrifuged at 20,630 x g for 10 min at room temperature. The lysates were mixed with sample buffer (cat. no. 30566-22; Nacalai Tesque, Inc.) with 2-mercapto ethanol and incubated at 100˚C for 3 min. Lysates containing 5-7 µg protein were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis using Mini Trans-Blot® Cell (cat. no. 153BR78145; Bio-Rad Laboratories, Inc.). The separated proteins were then transferred from the gel to polyvinylidene fluoride membranes (cat. no. 1704272; Bio-Rad Laboratories, Inc.) using the Trans-Blot®TurboTM System (cat. no. 690BR009070; Bio-Rad Laboratories, Inc.). The membranes were blocked for 5 min at room temperature with Every Blot blocking buffer (cat. no. 12010020; Bio-Rad Laboratories, Inc.) and incubated with anti-ZW10 (1:1,000; cat. no. 24561-1-AP, Proteintech, Inc.) and anti-α-tubulin (1:5,000; cat. no. 3873, clone DM1A, Cell Signaling Technology, Inc.) antibodies overnight at 4˚C. Following incubation, the membranes were washed in Tris-buffered saline containing 0.1% Tween-20 (TBS-T). The membranes were then incubated with appropriate secondary antibodies (1:5,000; anti-mouse IgG, cat. no. 7076, Cell Signaling Technology, Inc. and 1:5,000; anti-rabbit IgG, cat. no. 7074, Cell Signaling Technology, Inc.) for 1 h at room temperature and washed with TBS-T. Protein bands were detected using a ChemiDoc MP Imaging System (Bio-Rad Laboratories, Inc.). Quantitative analysis was performed using ImageLab software version 4.1 (Bio-Rad Laboratories, Inc.).

siRNA-mediated knockdown of KNTC1

The sequence (GGAAUGAUAUUGAGCUGCUAACAAA) of human KNTC1 siRNA was designed from Thermo Fisher Scientific, Inc. (cat. no. HSS114610). KNTC1 siRNA or negative control (cat. no. 12935-300; Invitrogen; Thermo Fisher Scientific, Inc.) was combined with Lipofectamine RNAiMAX (cat. no. 13778-030; Invitrogen; Thermo Fisher Scientific, Inc.) and incubated for 15 min at room temperature. The NCI-N87, KATOIII, MKN74 and TIG-1-20 cells were transfected with the KNTC1 siRNA or negative control-Lipofectamine RNAiMAX complexes and incubated at 37˚C for 3 days. At 3 days following the addition of the KNTC1 siRNA or negative control-Lipofectamine RNAiMAX complexes, the cells were harvested and processed for RT-qPCR and western blot analysis, and for the analysis of the frequency of lagging chromosomes.

Statistical analysis

All the statistical analyses were performed using Statcel 4 (https://oms-publ.main.jp/main/4steps4-hyo1/). The one-way ANOVA and Tukey-Kramer test were performed to assess differences in frequency of lagging chromosomes and KNTC1 mRNA expression. The Student's t test was used to assess the efficiency of KNTC1 knockdown and the frequency of lagging chromosomes and ZW10 protein expression following KNTC1 knockdown. Data are presented as the mean ± standard deviation. P-values #x003C;0.05 were considered to indicate statistically significant differences.

Results

Frequency of lagging chromosomes and expression levels of KNTC1 mRNA

To investigate the CIN status in GC cells, the frequency of lagging chromosomes was analyzed. The frequency of lagging chromosomes was significantly higher in the NCI-N87 and KATOIII cells, which exhibited the amplification of RTK genes, than in the MKN74 cells, which did not exhibit the amplification of RTK genes (Fig. 2). Only a small number of lagging chromosomes were observed in the TIG-1-20 cells.

Frequency of lagging chromosomes in
the NCI-N87, KATOIII, MKN74 and TIG-1-20 cells. The frequency of
lagging chromosomes was significantly higher in the NCI-N87 and
KATOIII cells than in the MKN74 cells. All data were analyzed using
one-way ANOVA and Tukey-Kramer test. **P#x003C;0.01.

Figure 2

Frequency of lagging chromosomes in the NCI-N87, KATOIII, MKN74 and TIG-1-20 cells. The frequency of lagging chromosomes was significantly higher in the NCI-N87 and KATOIII cells than in the MKN74 cells. All data were analyzed using one-way ANOVA and Tukey-Kramer test. **P#x003C;0.01.

The expression levels of KNTC1 mRNA were higher in the MKN74 cells than in the NCI-N87 and KATOIII cells, and were inversely associated with the frequency of lagging chromosomes (Fig. 3). In addition, the mRNA expression level of KNTC1 in the NCI-N87 cells was significantly lower than that in TIG-1-20 cells.

mRNA expression levels of KNTC1
in the NCI-N87, KATOIII, MKN74 and TIG-1-20 cells, as measured
using reverse transcription-quantitative PCR. KNTC1 mRNA
expression was higher in the MKN74 cells than in the NCI-N87 and
KATOIII cells and was inversely associated with the frequency of
lagging chromosomes. All data were analyzed using one-way ANOVA and
Tukey-Kramer test. *P#x003C;0.05. KNTC1,
kinetochore-associated 1 gene.

Figure 3

mRNA expression levels of KNTC1 in the NCI-N87, KATOIII, MKN74 and TIG-1-20 cells, as measured using reverse transcription-quantitative PCR. KNTC1 mRNA expression was higher in the MKN74 cells than in the NCI-N87 and KATOIII cells and was inversely associated with the frequency of lagging chromosomes. All data were analyzed using one-way ANOVA and Tukey-Kramer test. *P#x003C;0.05. KNTC1, kinetochore-associated 1 gene.

Frequency of lagging chromosomes and expression of ZW10 following KNTC1 knockdown

The present study then investigated whether the knockdown of KNTC1 increased the frequency of lagging chromosomes. The confirmation of the knockdown efficiency KNTC1 siRNA was performed using RT-qPCR (Fig. 4). The NCI-N87, KATOIII and MKN74 cells exhibited increased frequencies of lagging chromosomes following the knockdown of KNTC1 (Fig. 5A). These differences were statistically significant in the NCI-N87 and KATOIII cells. By contrast, no increases in lagging chromosomes were observed in the TIG-1-20 cells following the knockdown of KNTC1.

The NCI-N87, KATOIII, MKN74 and
TIG-1-20 cells were transfected with siRNA targeting KNTC1
or negative control (siControl). At 3 days following transfection,
total RNA was extracted and measured using reverse
transcription-quantitative PCR. KNTC1 mRNA expression was
significantly decreased following transfection with siRNA targeting
KNTC1 in all cell lines. All data were analyzed using the
Student's t-test. **P#x003C;0.01 vs. siControl
KNTC1, kinetochore-associated 1 gene.

Figure 4

The NCI-N87, KATOIII, MKN74 and TIG-1-20 cells were transfected with siRNA targeting KNTC1 or negative control (siControl). At 3 days following transfection, total RNA was extracted and measured using reverse transcription-quantitative PCR. KNTC1 mRNA expression was significantly decreased following transfection with siRNA targeting KNTC1 in all cell lines. All data were analyzed using the Student's t-test. **P#x003C;0.01 vs. siControl KNTC1, kinetochore-associated 1 gene.

Frequencies of lagging chromosomes in
NCI-N87, MKN74, TIG-1-20 and KATOIII cells transfected with siRNA
targeting KNTC1 or negative control (siControl) for 3 days.
(A) The frequency of lagging chromosomes was significantly
increased in the NCI-N87 and KATOIII cells transfected with siRNA
targeting KNTC1. All data were analyzed using the Student's t-test.
*P#x003C;0.05 vs. siControl; **P#x003C;0.01
vs. siControl. (B) The silencing off KNTC1 could lead to
intratumoral genetic heterogeneity in GC cells with the
amplification of RTK genes. KNTC1, kinetochore-associated 1
gene; GC, gastric cancer; RTKs, receptor tyrosine kinases.

Figure 5

Frequencies of lagging chromosomes in NCI-N87, MKN74, TIG-1-20 and KATOIII cells transfected with siRNA targeting KNTC1 or negative control (siControl) for 3 days. (A) The frequency of lagging chromosomes was significantly increased in the NCI-N87 and KATOIII cells transfected with siRNA targeting KNTC1. All data were analyzed using the Student's t-test. *P#x003C;0.05 vs. siControl; **P#x003C;0.01 vs. siControl. (B) The silencing off KNTC1 could lead to intratumoral genetic heterogeneity in GC cells with the amplification of RTK genes. KNTC1, kinetochore-associated 1 gene; GC, gastric cancer; RTKs, receptor tyrosine kinases.

In addition, to determine whether ZW10 compensated for KNTC1 function, ZW10 protein expression was investigated following KNTC1 knockdown. However, no changes in ZW10 protein expression were observed in any of the cell lines tested (Fig. 6).

ZW10 expression in NCI-N87, KATOIII,
MKN74 and TIG-1-20 cells. Cells were transfected with siRNA
targeting KNTC1 or negative control (siControl). (A) ZW10
expression was evaluated using western blot analysis, with
α-tubulin as the loading control. (B) Quantitative analysis using
ImageLab software. No change in ZW10 expression was observed
following the knockdown of KNTC1. All data were analyzed
using the Student's t-test. KNTC1, kinetochore-associated 1
gene.

Figure 6

ZW10 expression in NCI-N87, KATOIII, MKN74 and TIG-1-20 cells. Cells were transfected with siRNA targeting KNTC1 or negative control (siControl). (A) ZW10 expression was evaluated using western blot analysis, with α-tubulin as the loading control. (B) Quantitative analysis using ImageLab software. No change in ZW10 expression was observed following the knockdown of KNTC1. All data were analyzed using the Student's t-test. KNTC1, kinetochore-associated 1 gene.

Discussion

Deletion or loss of function of various kinetochore proteins, including KNTC1, has been reported to cause chromosome segregation abnormalities and induce aneuploidy and CIN in Drosophila and C. elegans (16-18). However, the role of KNTC1 in GC CIN is poorly understood. In the present study, it was found that GC cells with the amplification of RTK genes, including NCI-N87 and KATOIII cells, exhibited lower mRNA expression levels of KNTC1 and KNTC1 expression exhibited an inverse association with the frequency of lagging chromosomes (Figs. 2 and 3). Moreover, the frequency of lagging chromosomes in the NCI-N87, KATOIII and MKN74 cells increased following the knockdown of KNTC1 (Fig. 5A). These findings suggest that the suppression of the expression of the KNTC1 gene may contribute to CIN in GC. In particular, suppression of the expression of KNTC1 in GC cells exhibiting the amplification of RTK genes may enhance CIN and could lead to intratumoral genetic heterogeneity (Fig. 5B). Therefore, the restoration of normal KNTC1 expression levels may improve patient prognosis by alleviating intratumoral genetic heterogeneity through appropriate kinetochore-microtubule attachments.

ZW10 is located in the cytoplasm and endoplasmic reticulum (ER) during the interphase and is involved in transport between the ER and Golgi apparatus (20). During mitosis, ZW10 and KNTC1 are recruited to the kinetochore, where they form the RZZ complex with ZWILCH (21). When KNTC1 is present, the RZZ complex activates the SAC and recruits dynein/dynactin during mitosis. Therefore, it was hypothesized that ZW10 may compensate for the loss of function of KNTC1. However, ZW10 protein expression levels were not altered when KNTC1 was knocked down in all cell lines (Fig. 6). This finding is consistent with the findings of a previous study demonstrating that ZW10 protein levels were not altered by the expression of a mutant KNTC1 gene, which severely affected the localization of ZW10 in Drosophila (22); this suggests that ZW10 does not compensate for the function of KNTC1. This finding also suggests that there may be no association between ZW10 and CIN.

The overexpression of the KNTC1 gene has been observed in several types of cancer, suggesting that KNTC1 promotes cell proliferation and viability (23-25). However, in the present study, no inhibition of cell proliferation or increase in apoptotic bodies were observed following KNTC1 knockdown in KATOIII or MKN74 cells (Data S1 and Fig. S2), although increases in lagging chromosomes were observed. In the NCI-N87 cells, differences in cell proliferation were observed at 72 h following KNTC1 knockdown, but no apoptosis was observed. This difference suggests that the role of the KNTC1 gene may vary by cancer type. In fact, mRNA expression data from The Human Protein Atlas revealed poor survival rates of patients with GC exhibiting a low expression of KNTC1 (Data S1 and Fig. S3). Previous findings that the suppression of the expression of the KNTC1 gene contributes to CIN may support these data (26-28). In the future, additional large-scale studies using clinical samples are warranted to clarify the association between the KNTC1 gene and CIN and its causal association with patient prognosis.

In conclusion, the present study demonstrated that the knockdown of KNTC1 increased the frequency of lagging chromosomes in GC cells. These finding suggest that the suppression of the expression of KNTC1 may contribute to CIN in GC.

Supplementary Material

Giemsa-stained image of the lagging chromosome in NCI-N87 cells. Chromosomes remained on the metaphase plate and formed bridges in anaphase (red arrows).
Cell proliferation following KNTC1 knockdown. (A) No decrease in cell proliferation was observed in the MKN74, KATOIII and TIG-1-20 cells following KNTC1 knockdown, whereas a decrease in cell proliferation was observed in the NCI-N87 cells. All data were analyzed using the Student's t-test. *P<0.05 vs. siControl. (B) No increase in apoptosis was observed following KNTC1 knockdown in all four cell lines. DAPI staining; 60X objective. KNTC1, kinetochore-associated 1 gene.
Kaplan-Meier plot showing KNTC1 mRNA expression levels and outcomes of prognoses in patients with gastric cancer. In gastric cancer, a low KNTC1 expression was found to be associated with a poor prognosis. P=0.047, low expression vs. high expression. Kaplan-Meier plots were obtained from The Human Protein Atlas version 23.0) (https://www.proteinatlas.org/ENSG00000184445-KNTC1/cancer/stomach+cancer#STAD_TCGA). KNTC1, kinetochore-associated 1 gene.
Supplementary materials and methods

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The data generated in the present study may be requested from the corresponding author.

Authors' contributions

KK conceptualized the study. DO analyzed the data and wrote the original draft of the manuscript. KK reviewed and edited the original draft of the manuscript. KK and DO confirm the authenticity of all the raw data. Both authors have read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Sung H, Ferlay J, Siegel RL, Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar

2 

Sato Y, Okamoto K, Kawano Y, Kasai A, Kawaguchi T, Sagawa T, Sogabe M, Miyamoto H and Takayama T: Novel biomarkers of gastric cancer: Current research and future perspectives. J Clin Med. 12(4646)2023.PubMed/NCBI View Article : Google Scholar

3 

Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 513:202–209. 2014.PubMed/NCBI View Article : Google Scholar

4 

Ignatova EO, Kozlov E, Ivanov M, Mileyko V, Menshikova S, Sun H, Fedyanin M, Tryakin A and Stilidi I: Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma. World J Gastrointest Oncol. 14:628–645. 2022.PubMed/NCBI View Article : Google Scholar

5 

Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, Lee KW, Kim EH, Yim SY, Lee SH, et al: Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 23:4441–4449. 2017.PubMed/NCBI View Article : Google Scholar

6 

Nemtsova MV, Kuznetsova EB and Bure IV: Chromosomal instability in gastric cancer: Role in tumor development, progression, and therapy. Int J Mol Sci. 24(16961)2023.PubMed/NCBI View Article : Google Scholar

7 

Grillo F, Fassan M, Sarocchi F, Fiocca R and Mastracci L: HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice. World J Gastroenterol. 22:5879–5887. 2016.PubMed/NCBI View Article : Google Scholar

8 

Wakatsuki T, Yamamoto N, Sano T, Chin K, Kawachi H, Takahari D, Ogura M, Ichimura T, Nakayama I, Osumi H, et al: Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer. J Gastroenterol. 53:1186–1195. 2018.PubMed/NCBI View Article : Google Scholar

9 

Gassmann R, Essex A, Hu JS, Maddox PS, Motegi F, Sugimoto A, O'Rourke SM, Bowerman B, McLeod I, Yates III JR, et al: A new mechanism controlling kinetochore–microtubule interactions revealed by comparison of two dynein-targeting components: SPDL-1 and the Rod/Zwilch/Zw10 complex. Genes Dev. 22:2385–2399. 2008.PubMed/NCBI View Article : Google Scholar

10 

Lara-Gonzalez P, Westhorpe FG and Taylor SS: The spindle assembly checkpoint. Curr Biol. 22:R966–R980. 2012.PubMed/NCBI View Article : Google Scholar

11 

Vallee RB, Varma D and Dujardin DL: ZW10 function in mitotic checkpoint control, dynein targeting, and membrane trafficking: Is dynein the unifying theme? Cell Cycle. 5:2447–2451. 2006.PubMed/NCBI View Article : Google Scholar

12 

Cmentowski V, Ciossani G, d'Amico E, Wohlgemuth S, Owa M, Dynlacht B and Musacchio A: RZZ-Spindly and CENP-E form an integrated platform to recruit dynein to the kinetochore corona. EMBO J. 42(e114838)2023.PubMed/NCBI View Article : Google Scholar

13 

Pereira C, Reis RM, Gama JB, Celestino R, Cheerambathur DK, Carvalho AX and Gassmann R: Self-assembly of the RZZ complex into filaments drives kinetochore expansion in the absence of microtubule attachment. Curr Biol. 28:3408–3421.e8. 2018.PubMed/NCBI View Article : Google Scholar

14 

Barbosa J, Conde C and Sunkel C: RZZ-SPINDLY-DYNEIN: You got to keep 'em separated. Cell Cycle. 19:1716–1726. 2020.PubMed/NCBI View Article : Google Scholar

15 

Zhang G, Lischetti T, Hayward DG and Nilsson J: Distinct domains in Bub1 localize RZZ and BubR1 to kinetochores to regulate the checkpoint. Nat Commun. 6(7162)2015.PubMed/NCBI View Article : Google Scholar

16 

Lara-Gonzalez P, Pines J and Desai A: Spindle assembly checkpoint activation and silencing at kinetochores. Semin Cell Dev Biol. 117:86–98. 2021.PubMed/NCBI View Article : Google Scholar

17 

Scaërou F, Aguilera I, Saunders R, Kane N, Blottière L and Karess R: The rough deal protein is a new kinetochore component required for accurate chromosome segregation in Drosophila. J Cell Sci. 112:3757–3768. 1999.PubMed/NCBI View Article : Google Scholar

18 

Williams BC, Li Z, Liu S, Williams EV, Leung G, Yen TJ and Goldberg ML: Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions. Mol Biol Cell. 14:1379–1391. 2003.PubMed/NCBI View Article : Google Scholar

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

20 

Hirose H, Arasaki K, Dohmae N, Takio K, Hatsuzawa K, Nagahama M, Tani K, Yamamoto A, Tohyama M and Tagaya M: Implication of ZW10 in membrane trafficking between the endoplasmic reticulum and Golgi. EMBO J. 23:1267–1278. 2004.PubMed/NCBI View Article : Google Scholar

21 

Défachelles L, Raich N, Terracol R, Baudin X, Williams B, Goldberg M and Karess RE: RZZ and Mad1 dynamics in Drosophila mitosis. Chrom Res. 23:333–342. 2015.PubMed/NCBI View Article : Google Scholar

22 

Williams BC and Goldberg ML: Determinants of drosophila zw10 protein localization and function. J Cell Sci. 107:785–798. 1994.PubMed/NCBI View Article : Google Scholar

23 

Zhengxiang Z, Yunxiang T, Zhiping L and Zhimin Y: KNTC1 knockdown suppresses cell proliferation of colon cancer. 3 Biotech. 11(262)2021.PubMed/NCBI View Article : Google Scholar

24 

Liu L, Chen H, Chen X, Yao C, Shen W and Jia C: KNTC1 as a putative tumor oncogene in pancreatic cancer. J Cancer Res Clin Oncol. 149:3023–3031. 2023.PubMed/NCBI View Article : Google Scholar

25 

Liu CT, Min L, Wang YJ, Li P, Wu YD and Zhang ST: shRNA-mediated knockdown of KNTC1 suppresses cell viability and induces apoptosis in esophageal squamous cell carcinoma. Int J Oncol. 54:1053–1060. 2019.PubMed/NCBI View Article : Google Scholar

26 

Bakhoum SF and Cantley LC: The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 174:1347–1360. 2018.PubMed/NCBI View Article : Google Scholar

27 

Bakhoum SF, Ngo B, Laughney AM, Cavallo JA, Murphy CJ, Ly P, Shah P, Sriram RK, Watkins TBK, Taunk NK, et al: Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 553:467–472. 2018.PubMed/NCBI View Article : Google Scholar

28 

Sansregret L, Vanhaesebroeck B and Swanton C: Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol. 15:139–150. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
Copy and paste a formatted citation
Spandidos Publications style
Ohsaki D and Kanayama K: Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells. Med Int 5: 59, 2025.
APA
Ohsaki, D., & Kanayama, K. (2025). Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells. Medicine International, 5, 59. https://doi.org/10.3892/mi.2025.258
MLA
Ohsaki, D., Kanayama, K."Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells". Medicine International 5.5 (2025): 59.
Chicago
Ohsaki, D., Kanayama, K."Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells". Medicine International 5, no. 5 (2025): 59. https://doi.org/10.3892/mi.2025.258
Copy and paste a formatted citation
x
Spandidos Publications style
Ohsaki D and Kanayama K: Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells. Med Int 5: 59, 2025.
APA
Ohsaki, D., & Kanayama, K. (2025). Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells. Medicine International, 5, 59. https://doi.org/10.3892/mi.2025.258
MLA
Ohsaki, D., Kanayama, K."Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells". Medicine International 5.5 (2025): 59.
Chicago
Ohsaki, D., Kanayama, K."Downregulation of kinetochore‑associated 1 gene increases lagging chromosomes and contributes to chromosomal instability in gastric cancer cells". Medicine International 5, no. 5 (2025): 59. https://doi.org/10.3892/mi.2025.258
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team